BlackRock, Inc. 13D and 13G filings for AcelRx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BLACKROCK INC BLK |
113,302 1.900% |
-168,745 (-59.83%) |
Filing |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX |
BLACKROCK INC BLK |
282,047 5.700% |
1,446 (+0.52%) |
Filing |